You are now leaving Lundbeck.com/ie

You are now leaving Lundbeck Ireland's website (www.lundbeck.com/ie) for an external website. External links are provided as a resource to the viewer. Lundbeck Ireland are not responsible for the external website and its content.

Leave site now

Cancel

Products

Names and Compounds of our Products 

Lundbeck has a broad range of products within brain diseases. With registered products in more than 100 countries, we leverage our global presence to bring innovative therapies to people living with brain diseases around the world. 

Abilify Maintena®

Aripiprazole

Brintellix®

Vortioxetine

Cipramil®

Citalopram

Clopixol®

Zuclopenthixol

Depixol®

Flupentixol

Ebixa®

Memantine

Lexapro®

Escitalopram Oxalate

Selincro®

Nalmefene

Vyepti®

Eptinezumab

Medicines.ie

To view Patient Information Leaflets (PIL) or the Summary of Product Characteristics for these products, please visit: https://www.medicines.ie/

Visit medicines.ie

Report an Adverse Drug Reaction

Reporting of potential adverse drug reactions is important in order for us to continuously evaluate the benefits and risks of our products and take proactive action as warranted.

Report an Adverse Drug Reaction

More from lundbeck

Research and Development

R&D of new and improved treatments is at the core of what we do.

Our Science

Lundbeck has developed some of the world’s most widely prescribed therapies.

Restoring Brain Health

What brain health means to us at Lundbeck.